Compound Detail
CHEMBL4303201
CATEQUENTINIB 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL4303201 |
| Name | CATEQUENTINIB |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | KSMZEXLVHXZPEF-UHFFFAOYSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
10
Publications
5
Known Names
20
Indications
4
Mechanisms
Molecular Properties
407.4
MW (Da)
4.83
ALogP
5
HBA
2
HBD
82.4
PSA (Ų)
0.48
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Vascular endothelial growth factor receptor 2 inhibitor | INHIBITOR | Vascular endothelial growth factor receptor 2 | ✓ | ✓ |
| Vascular endothelial growth factor receptor 3 inhibitor | INHIBITOR | Vascular endothelial growth factor receptor 3 | ✓ | ✓ |
| Stem cell growth factor receptor inhibitor | INHIBITOR | Mast/stem cell growth factor receptor Kit | ✓ | ✓ |
| Platelet-derived growth factor receptor beta inhibitor | INHIBITOR | Platelet-derived growth factor receptor beta | ✓ | ✓ |
Indications
Carcinoma, Hepatocellular Carcinoma, Non-Small-Cell Lung Kidney Neoplasms Leiomyosarcoma Lung Neoplasms Lung Neoplasms Lung Neoplasms Ovarian Neoplasms Sarcoma Sarcoma Sarcoma, Alveolar Soft Part Sarcoma, Synovial Small Cell Lung Carcinoma Adenocarcinoma of Lung Biliary Tract Neoplasms Bone Neoplasms Brain Stem Neoplasms Breast Neoplasms Breast Neoplasms Bronchiolitis Obliterans Syndrome
Activity Summary
IC50 3 meas. best 9.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 9.7 | 9.7 | 0.2 | 1 |
| Platelet-derived growth factor receptor beta CHEMBL1913 | IC50 | 6.94 | 6.94 | 115.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 4.77 | 4.77 | 17000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Vascular endothelial growth factor receptor 2 | IC50 | = | 0.2 | nM | 9.7 | Inhibition of recombinant human VEGFR2 using Poly (Glu,Tyr) 4:1 as substrate inc... | 37285684 |
| Platelet-derived growth factor receptor beta | IC50 | = | 115.0 | nM | 6.94 | Inhibition of recombinant human PDGFRbeta using Poly (Glu,Tyr) 4:1 as substrate ... | 37285684 |
| MDA-MB-231 | IC50 | = | 17000.0 | nM | 4.77 | Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viabil... | 38870832 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4651402 | Vero C1008 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 37285684 | 10.1016/j.ejmech.2023.115535 | Vascular endothelial growth factor receptor 2 | 2 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| - | 10.1101/2020.04.21.054387 | SARS-CoV-2 | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
| 38870832 | 10.1016/j.ejmech.2024.116561 | MDA-MB-231 | 1 |
| 37285684 | 10.1016/j.ejmech.2023.115535 | Platelet-derived growth factor receptor beta | 1 |
Data from ChEMBL 36 via Core Engine